Actively Recruiting
A Registry Study of Biomarkers in Heart Valve Disease
Led by Beijing Institute of Heart, Lung and Blood Vessel Diseases · Updated on 2024-01-26
200000
Participants Needed
1
Research Sites
730 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches
CONDITIONS
Official Title
A Registry Study of Biomarkers in Heart Valve Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital
You will not qualify if you...
- Age < 18 years
- Failure to obtain medical records and ultrasound data
- Refuse follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China, 100029
Actively Recruiting
Research Team
Y
Yuan Wang, Dr
CONTACT
R
Rui Lin, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here